Cycloguanil (BioDeep_00000539112)

   


代谢物信息卡片


Cycloguanil

化学式: C11H14ClN5 (251.0938)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1(N=C(N=C(N1C2=CC=C(C=C2)Cl)N)N)C
InChI: InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)

描述信息

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
D007004 - Hypoglycemic Agents > D001645 - Biguanides

同义名列表

1 个代谢物同义名

Cycloguanil



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Ryohkan Funakoshi, Yukana Tomoda, Toshiyuki Kudo, Kenichi Furihata, Hiroyuki Kusuhara, Kiyomi Ito. Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers. British journal of clinical pharmacology. 2019 07; 85(7):1454-1463. doi: 10.1111/bcp.13914. [PMID: 30845361]
  • Pablo Villoslada, Gemma Vila, Valeria Colafrancesco, Beatriz Moreno, Begoña Fernandez-Diez, Raquel Vazquez, Inna Pertsovskaya, Irati Zubizarreta, Irene Pulido-Valdeolivas, Joaquin Messeguer, Gloria Vendrell-Navarro, Jose Maria Frade, Noelia López-Sánchez, Meritxell Teixido, Ernest Giralt, Mar Masso, Jason C Dugas, Dmitri Leonoudakis, Karen D Lariosa-Willingham, Lawrence Steinman, Angel Messeguer. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2019 07; 16(3):808-827. doi: 10.1007/s13311-019-00717-4. [PMID: 30815844]
  • Maarten van der Velden, Albert Bilos, Jeroen J M W van den Heuvel, Sanna R Rijpma, Evelien G E Hurkmans, Robert W Sauerwein, Frans G M Russel, Jan B Koenderink. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates. Malaria journal. 2017 10; 16(1):422. doi: 10.1186/s12936-017-2062-y. [PMID: 29061131]
  • Maxime G Corral, Julie Leroux, Keith A Stubbs, Joshua S Mylne. Herbicidal properties of antimalarial drugs. Scientific reports. 2017 03; 7(?):45871. doi: 10.1038/srep45871. [PMID: 28361906]
  • Thanika Promchai, Atchara Jaidee, Sarot Cheenpracha, Kongkiat Trisuwan, Roonglawan Rattanajak, Sumalee Kamchonwongpaisan, Surat Laphookhieo, Stephen G Pyne, Thunwadee Ritthiwigrom. Antimalarial Oxoprotoberberine Alkaloids from the Leaves of Miliusa cuneata. Journal of natural products. 2016 Apr; 79(4):978-83. doi: 10.1021/acs.jnatprod.5b01054. [PMID: 26928423]
  • Domagoj Dinter, Goran Gajski, Ana-Marija Domijan, Vera Garaj-Vrhovac. Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro. Fundamental & clinical pharmacology. 2015 Dec; 29(6):575-85. doi: 10.1111/fcp.12153. [PMID: 26434663]
  • Phurpa Wangchuk, Wangchuk Phurpa, Paul A Keller, Stephen G Pyne, Wilford Lie, Anthony C Willis, Roonglawan Rattanajak, Sumalee Kamchonwongpaisan. A new protoberberine alkaloid from Meconopsis simplicifolia (D. Don) Walpers with potent antimalarial activity against a multidrug resistant Plasmodium falciparum strain. Journal of ethnopharmacology. 2013 Dec; 150(3):953-9. doi: 10.1016/j.jep.2013.09.052. [PMID: 24120516]
  • Domagoj Dinter, Goran Gajski, Vera Garaj-Vrhovac. An alkaline comet assay study on the antimalarial drug atovaquone in human peripheral blood lymphocytes: a study based on clinically relevant concentrations. Journal of applied toxicology : JAT. 2013 Jan; 33(1):56-62. doi: 10.1002/jat.1711. [PMID: 21735454]
  • J Enrique Salcedo-Sora, Edwin Ochong, Susan Beveridge, David Johnson, Alexis Nzila, Giancarlo A Biagini, Paul A Stocks, Paul M O'Neill, Sanjeev Krishna, Patrick G Bray, Stephen A Ward. The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters. The Journal of biological chemistry. 2011 Dec; 286(52):44659-68. doi: 10.1074/jbc.m111.286054. [PMID: 21998306]
  • Geoffrey S Dow, Montip Gettayacamin, Pranee Hansukjariya, Rawiwan Imerbsin, Srawuth Komcharoen, Jetsumon Sattabongkot, Dennis Kyle, Wilbur Milhous, Simon Cozens, David Kenworthy, Anne Miller, Jim Veazey, Colin Ohrt. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malaria journal. 2011 Jul; 10(?):212. doi: 10.1186/1475-2875-10-212. [PMID: 21801400]
  • Chiara Tommasi, Rita Bellagamba, Massimo Tempestilli, Antonio D'Avolio, Anna L Gallo, Jelena Ivanovic, Emanuele Nicastri, Leopoldo P Pucillo, Pasquale Narciso. Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis. Malaria journal. 2011 May; 10(?):141. doi: 10.1186/1475-2875-10-141. [PMID: 21600016]
  • Goran Gajski, Domagoj Dinter, Vera Garaj-Vrhovac. In vitro effect of the antimalarial drug proguanil hydrochloride on viability and DNA damage in human peripheral blood lymphocytes. Environmental toxicology and pharmacology. 2010 Nov; 30(3):257-63. doi: 10.1016/j.etap.2010.07.001. [PMID: 21787658]
  • Hetty Jolink, Jan den Hartigh, Leo G Visser, Cees van Nieuwkoop. Pancytopenia due to proguanil toxicity in a returning traveller with fever. European journal of clinical pharmacology. 2010 Aug; 66(8):811-2. doi: 10.1007/s00228-010-0824-3. [PMID: 20407763]
  • Julius Olugbenga Soyinka, Cyprian Ogbonna Onyeji. Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2010 Feb; 39(4):213-8. doi: 10.1016/j.ejps.2009.11.012. [PMID: 19961932]
  • Cullen K T Pang, Joshua H Hunter, Ramesh Gujjar, Ramulu Podutoori, Julie Bowman, Devaraja G Mudeppa, Pradipsinh K Rathod. Catalytic and ligand-binding characteristics of Plasmodium falciparum serine hydroxymethyltransferase. Molecular and biochemical parasitology. 2009 Nov; 168(1):74-83. doi: 10.1016/j.molbiopara.2009.06.011. [PMID: 19591883]
  • Chakradhara Rao Uppugunduri Satyanarayana, Anichavezhi Devendran, Muthukumaran Jayaraman, Jayakanthan Mannu, Premendu P Mathur, Shewade Deepak Gopal, Krishnamoorthy Rajagopal, Adithan Chandrasekaran. Influence of the genetic polymorphisms in the 5' flanking and exonic regions of CYP2C19 on proguanil oxidation. Drug metabolism and pharmacokinetics. 2009; 24(6):537-48. doi: 10.2133/dmpk.24.537. [PMID: 20045989]
  • Tewari Tushar, Thomas Vinod, Sundaram Rajan, Chanolean Shashindran, Chandrasekaran Adithan. Effect of honey on CYP3A4, CYP2D6 and CYP2C19 enzyme activity in healthy human volunteers. Basic & clinical pharmacology & toxicology. 2007 Apr; 100(4):269-72. doi: 10.1111/j.1742-7843.2006.00039.x. [PMID: 17371531]
  • Nathalie L Leveque, William N Charman, Francis C K Chiu. Sensitive method for the quantitative determination of proguanil and its metabolites in rat blood and plasma by liquid chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2006 Jan; 830(2):314-21. doi: 10.1016/j.jchromb.2005.11.004. [PMID: 16310420]
  • K Na-Bangchang, C Manyando, R Ruengweerayut, D Kioy, M Mulenga, G B Miller, J Konsil. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. European journal of clinical pharmacology. 2005 Sep; 61(8):573-82. doi: 10.1007/s00228-005-0969-7. [PMID: 16041597]
  • Michael Alifrangis, Inge T Christensen, Flemming S Jørgensen, Anita M Rønn, Jimmy E Weng, Ming Chen, Ib C Bygbjerg, Worachart Sirawaraporn, Yaseelan Palarasah, Claus Koch. Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum. Malaria journal. 2004 Jun; 3(?):16. doi: 10.1186/1475-2875-3-16. [PMID: 15193156]
  • Janelle M Hoskins, Gillian M Shenfield, Annette S Gross. Concordance between proguanil phenotype and CYP2C19 genotype in Chinese. European journal of clinical pharmacology. 2003 Nov; 59(8-9):611-4. doi: 10.1007/s00228-003-0665-4. [PMID: 13680037]
  • R McGready, K Stepniewska, M D Edstein, T Cho, G Gilveray, S Looareesuwan, N J White, F Nosten. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. European journal of clinical pharmacology. 2003 Oct; 59(7):545-52. doi: 10.1007/s00228-003-0652-9. [PMID: 12955371]
  • R McGready, K Stepniewska, E Seaton, T Cho, D Cho, A Ginsberg, M D Edstein, E Ashley, S Looareesuwan, N J White, F Nosten. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. European journal of clinical pharmacology. 2003 Oct; 59(7):553-7. doi: 10.1007/s00228-003-0651-x. [PMID: 12955370]
  • Tashinga E Bapiro, Tommy B Andersson, Charlotta Otter, Julia A Hasler, Collen M Masimirembwa. Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. European journal of clinical pharmacology. 2002 Nov; 58(8):537-42. doi: 10.1007/s00228-002-0512-z. [PMID: 12451431]
  • Mita M Thapar, Michael Ashton, Niklas Lindegårdh, Yngve Bergqvist, Sabina Nivelius, Inger Johansson, Anders Björkman. Time-dependent pharmacokinetics and drug metabolism of atovaquone plus proguanil (Malarone) when taken as chemoprophylaxis. European journal of clinical pharmacology. 2002 Apr; 58(1):19-27. doi: 10.1007/s00228-002-0426-9. [PMID: 11956669]
  • Zeruesenay Desta, Xiaojiong Zhao, Jae-Gook Shin, David A Flockhart. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clinical pharmacokinetics. 2002; 41(12):913-58. doi: 10.2165/00003088-200241120-00002. [PMID: 12222994]
  • Jean François Chaulet, Patrice Nony, Fabien Bévalot, Pascal Girard, Sylvie Chabaud, Cyril Mounier, Pascal Clair, Jean Pierre Boissel, Gilles Grelaud. Bioequivalence evaluation of a fixed combination of chloroquine and proguanil in a capsule formulation versus a standard medication. Arzneimittel-Forschung. 2002; 52(5):407-12. doi: 10.1055/s-0031-1299906. [PMID: 12087928]
  • S N Muchoh, B R Ogutu, C R Newton, G O Kokwar. High-performance liquid chromatographic determination of diazepam in plasma of children with severe malaria. Journal of chromatography. B, Biomedical sciences and applications. 2001 Sep; 761(2):255-9. doi: 10.1016/s0378-4347(01)00284-5. [PMID: 11587356]
  • R B Taylor, R G Reid, A S Low. Analysis of proguanil and its metabolites by application of the sweeping technique in micellar electrokinetic chromatography. Journal of chromatography. A. 2001 May; 916(1-2):201-6. doi: 10.1016/s0021-9673(00)01035-9. [PMID: 11382292]
  • K Herrlin, A Y Massele, G Rimoy, C Alm, M Rais, O Ericsson, L Bertilsson, L L Gustafsson. Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype. Clinical pharmacology and therapeutics. 2000 Aug; 68(2):189-98. doi: 10.1067/mcp.2000.108583. [PMID: 10976550]
  • J A Kolawole, A Mustapha, I Abdul-Aguye, N Ochekpe, R B Taylor. Effects of cimetidine on the pharmacokinetics of proguanil in healthy subjects and in peptic ulcer patients. Journal of pharmaceutical and biomedical analysis. 1999 Sep; 20(5):737-43. doi: 10.1016/s0731-7085(99)00058-8. [PMID: 10701981]
  • C Gillotin, J P Mamet, L Veronese. Lack of a pharmacokinetic interaction between atovaquone and proguanil. European journal of clinical pharmacology. 1999 Jun; 55(4):311-5. doi: 10.1007/s002280050634. [PMID: 10424325]
  • J M Hoskins, G M Shenfield, A S Gross. Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population. British journal of clinical pharmacology. 1998 Nov; 46(5):499-504. doi: 10.1046/j.1365-2125.1998.00807.x. [PMID: 9833604]
  • Y Bergqvist, L Funding, B Krysèn, T Leek, K Yvell. Improved validated assay for the determination of proguanil and its metabolites in plasma, whole blood, and urine using solid-phase extraction and high-performance liquid chromatography. Therapeutic drug monitoring. 1998 Jun; 20(3):325-30. doi: 10.1097/00007691-199806000-00014. [PMID: 9631931]
  • N A Helsby, S A Ward, R A Parslew, P S Friedmann, L E Rhodes. Hepatic cytochrome P450 CYP2C activity in psoriasis: studies using proguanil as a probe compound. Acta dermato-venereologica. 1998 Mar; 78(2):81-3. doi: 10.1080/000155598433359. [PMID: 9534880]
  • A Sabchareon, P Attanath, P Phanuaksook, P Chanthavanich, Y Poonpanich, D Mookmanee, T Chongsuphajaisiddhi, B M Sadler, Z Hussein, C J Canfield, D B Hutchinson. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1998 Mar; 92(2):201-6. doi: 10.1016/s0035-9203(98)90749-0. [PMID: 9764334]
  • M D Edstein, A E Yeo, G D Shanks, K H Rieckmann. Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates. Acta tropica. 1997 Sep; 66(3):127-35. doi: 10.1016/s0001-706x(97)00044-2. [PMID: 9210963]
  • U Jeppesen, B B Rasmussen, K Brøsen. Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanide. Clinical pharmacology and therapeutics. 1997 Sep; 62(3):279-86. doi: 10.1016/s0009-9236(97)90030-8. [PMID: 9333103]
  • C Funck-Brentano, L Becquemont, A Lenevu, A Roux, P Jaillon, P Beaune. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments. The Journal of pharmacology and experimental therapeutics. 1997 Feb; 280(2):730-8. doi: . [PMID: 9023285]
  • A E Yeo, K K Seymour, K H Rieckmann, R I Christopherson. Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture. Annals of tropical medicine and parasitology. 1997 Jan; 91(1):17-23. doi: 10.1080/00034983.1997.11813107. [PMID: 9093425]
  • M Kusaka, R Setiabudy, K Chiba, T Ishizaki. Simultaneous measurement of proguanil and its metabolites in human plasma and urine by reversed-phase high-performance liquid chromatography, and its preliminary application in relation to genetically determined S-mephenytoin 4'-hydroxylation status. The American journal of tropical medicine and hygiene. 1996 Feb; 54(2):189-96. doi: 10.4269/ajtmh.1996.54.189. [PMID: 8619446]
  • A A Somogyi, H A Reinhard, F Bochner. Effects of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in healthy volunteers. European journal of clinical pharmacology. 1996; 50(5):417-9. doi: 10.1007/s002280050133. [PMID: 8839666]
  • J A Kolawole, R B Taylor, R R Moody. Determination of proguanil and metabolites in small sample volumes of whole blood stored on filter paper by high-performance liquid chromatography. Journal of chromatography. B, Biomedical applications. 1995 Dec; 674(1):149-54. doi: 10.1016/0378-4347(95)00293-3. [PMID: 8749264]
  • C Alexander, D Nathwani, N Zimbler, R B Taylor. Correlation between proguanil and metabolites in plasma and saliva. The Journal of antimicrobial chemotherapy. 1995 Dec; 36(6):1113-5. doi: 10.1093/jac/36.6.1113. [PMID: 8821621]
  • E K Mberu, T Wansor, H Sato, Y Nishikawa, W M Watkins. Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1995 Nov; 89(6):658-9. doi: 10.1016/0035-9203(95)90434-4. [PMID: 8594689]
  • J E Touze, A Keundjian, T Fusai, J C Doury. Human pharmacokinetics of chloroquine and proguanil delivered in a single capsule for malaria chemoprophylaxis. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ). 1995 Sep; 46(3):158-60. doi: NULL. [PMID: 8533017]
  • C Partovian, E Jacqz-Aigrain, A Keundjian, P Jaillon, C Funck-Brentano. Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans. Clinical pharmacology and therapeutics. 1995 Sep; 58(3):257-63. doi: 10.1016/0009-9236(95)90241-4. [PMID: 7554698]
  • R Setiabudy, M Kusaka, K Chiba, I Darmansjah, T Ishizaki. Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population. British journal of clinical pharmacology. 1995 Mar; 39(3):297-303. doi: 10.1111/j.1365-2125.1995.tb04452.x. [PMID: 7619672]
  • A E Yeo, M D Edstein, G D Shanks, K H Rieckmann. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers. Annals of tropical medicine and parasitology. 1994 Dec; 88(6):587-94. doi: 10.1080/00034983.1994.11812909. [PMID: 7893172]
  • M D Edstein, G D Shanks, P Teja-Isavadharm, K H Rieckmann, H K Webster. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. British journal of clinical pharmacology. 1994 Jan; 37(1):67-70. doi: 10.1111/j.1365-2125.1994.tb04241.x. [PMID: 8148220]
  • K Brøsen, E Skjelbo, H Flachs. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark. British journal of clinical pharmacology. 1993 Aug; 36(2):105-8. doi: 10.1111/j.1365-2125.1993.tb04204.x. [PMID: 8398577]
  • N A Helsby, G Edwards, A M Breckenridge, S A Ward. The multiple dose pharmacokinetics of proguanil. British journal of clinical pharmacology. 1993 Jun; 35(6):653-6. doi: 10.1111/j.1365-2125.1993.tb04197.x. [PMID: 8329294]
  • J Wangboonskul, N J White, F Nosten, F ter Kuile, R R Moody, R B Taylor. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. European journal of clinical pharmacology. 1993; 44(3):247-51. doi: 10.1007/bf00271366. [PMID: 8491239]
  • C Funck-Brentano, O Bosco, E Jacqz-Aigrain, A Keundjian, P Jaillon. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans. Clinical pharmacology and therapeutics. 1992 May; 51(5):507-12. doi: 10.1038/clpt.1992.55. [PMID: 1587064]
  • E Petersen, H Flachs, B Høgh, A P Hanson, A Björkman, E F Hvidberg. Plasma, erythrocyte and urine concentrations of chlorproguanil and two metabolites in man after different doses. The Journal of tropical medicine and hygiene. 1991 Jun; 94(3):199-205. doi: NULL. [PMID: 2051526]
  • S A Ward, N A Helsby, E Skjelbo, K Brøsen, L F Gram, A M Breckenridge. The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study. British journal of clinical pharmacology. 1991 Jun; 31(6):689-92. doi: 10.1111/j.1365-2125.1991.tb05594.x. [PMID: 1867963]
  • N A Helsby, S A Ward, G Edwards, R E Howells, A M Breckenridge. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. British journal of clinical pharmacology. 1990 Oct; 30(4):593-8. doi: 10.1111/j.1365-2125.1990.tb03818.x. [PMID: 2291871]
  • W M Watkins, E K Mberu, C G Nevill, S A Ward, A M Breckenridge, D K Koech. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990 Jul; 84(4):492-5. doi: 10.1016/0035-9203(90)90010-c. [PMID: 2091335]
  • M D Edstein, J R Veenendaal, K H Rieckmann. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Chemotherapy. 1990; 36(3):169-76. doi: 10.1159/000238763. [PMID: 2186899]
  • S A Ward, W M Watkins, E Mberu, J E Saunders, D K Koech, H M Gilles, R E Howells, A M Breckenridge. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. British journal of clinical pharmacology. 1989 Jun; 27(6):781-7. doi: 10.1111/j.1365-2125.1989.tb03440.x. [PMID: 2757894]
  • H V Scott, M D Edstein, J R Veenendaal, K H Rieckmann. A sensitive bioassay for serum cycloguanil using Plasmodium falciparum in vitro. International journal for parasitology. 1988 Jul; 18(5):605-9. doi: 10.1016/0020-7519(88)90094-x. [PMID: 3049411]
  • M D Edstein, J R Veenendaal, H V Scott, K H Rieckmann. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man. Chemotherapy. 1988; 34(5):385-92. doi: 10.1159/000238597. [PMID: 3180907]
  • J R Veenendaal, M D Edstein, K H Rieckmann. Pharmacokinetics of chlorproguanil in man after a single oral dose of Lapudrine. Chemotherapy. 1988; 34(4):275-83. doi: NULL. [PMID: 3208546]
  • Y Wattanagoon, R B Taylor, R R Moody, N A Ochekpe, S Looareesuwan, N J White. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. British journal of clinical pharmacology. 1987 Dec; 24(6):775-80. doi: 10.1111/j.1365-2125.1987.tb03245.x. [PMID: 3440097]
  • I Bygbjerg, P Ravn, A Rønn, H Flachs, E F Hvidberg. Human pharmacokinetics of proguanil and its metabolites. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ). 1987 Jun; 38(2):77-80. doi: NULL. [PMID: 3629140]
  • R B Taylor, R R Moody, N A Ochekpe. Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography. Journal of chromatography. 1987 May; 416(2):394-9. doi: 10.1016/0378-4347(87)80526-1. [PMID: 3611272]
  • E M Chiluba, K A Fletcher, A H Price. The pharmacokinetics of proguanil in human subjects following a single oral dose. African journal of medicine and medical sciences. 1987 Mar; 16(1):43-6. doi: NULL. [PMID: 3037875]
  • M D Edstein, J R Veenendaal. Chlorproguanil and chlorcycloguanil concentrations in human plasma and urine after Lapudrine administration. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1987; 81(1):136-9. doi: 10.1016/0035-9203(87)90305-1. [PMID: 3445299]
  • J A Kelly, K A Fletcher. High-performance liquid chromatographic method for the determination of proguanil and cycloguanil in biological fluids. Journal of chromatography. 1986 Sep; 381(2):464-71. doi: 10.1016/s0378-4347(00)83616-6. [PMID: 3760104]
  • M D Edstein. Simultaneous measurement of proguanil and cycloguanil in human plasma by high-performance liquid chromatography. Journal of chromatography. 1986 Jul; 380(1):184-9. doi: 10.1016/s0378-4347(00)83641-5. [PMID: 3745382]
  • I C Bygbjerg, H Flachs. Effect of oral proguanil on human lymphocyte proliferation. European journal of clinical pharmacology. 1986; 30(2):249-51. doi: 10.1007/bf00614314. [PMID: 3709655]
  • I C Bygbjerg. Effect of proguanil and cycloguanil on human lymphocytes in vitro. European journal of clinical pharmacology. 1985; 28(3):287-90. doi: 10.1007/bf00543325. [PMID: 3874067]
  • L H Schmidt, R N Rossan. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys. Antimicrobial agents and chemotherapy. 1984 Nov; 26(5):611-42. doi: 10.1128/aac.26.5.611. [PMID: 6393864]
  • R R Moody, A B Selkirk, R B Taylor. High-performance liquid chromatography of proguanil, cycloguanil and 4-chlorophenylbiguanide using hydrophobic pairing ion and its application to serum assay. Journal of chromatography. 1980 Jun; 182(3-4):359-67. doi: 10.1016/s0378-4347(00)81485-1. [PMID: 7391178]
  • M F Lokhandwala, J P Buckley, B S Jandhyala. Studies on the mechanism of the cardiovascualr effects of methyldopa. European journal of pharmacology. 1976 May; 37(1):79-89. doi: 10.1016/0014-2999(76)90010-8. [PMID: 6292]
  • C Salerno, J E Churchich, P M Fasella. Fluorescence polarization studies on the binding between glutamate dehydrogenase and cytoplasmic aspartate aminotransferase. The Italian journal of biochemistry. 1975 Nov; 24(6):351-9. doi: NULL. [PMID: 3487]